puregon solutie injectabila in cartus 300 ui/0,36 ml
merck sharp&dohme limited - follitropinum beta - solutie injectabila in cartus - 300 ui/0,36 ml
puregon solutie injectabila in cartus 600 ui/0,72 ml
merck sharp&dohme limited - follitropinum beta - solutie injectabila in cartus - 600 ui/0,72 ml
orgalutran solutie injectabila in seringa preumpluta 0,25 mg/0,5 ml
merck sharp&dohme limited - ganirelixum - solutie injectabila in seringa preumpluta - 0,25 mg/0,5 ml
elonva solutie injectabila in seringa preumpluta 100 mcg/0,5 ml
merck sharp&dohme limited - corifollitropinum alfa - solutie injectabila in seringa preumpluta - 100 mcg/0,5 ml
elonva solutie injectabila in seringa preumpluta 150 mcg/0,5 ml
merck sharp&dohme limited - corifollitropinum alfa - solutie injectabila in seringa preumpluta - 150 mcg/0,5 ml
astrium 5 mg
accord healthcare limited - marea britanie - rosuvastatinum - compr. film. - 5mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
astrium 10 mg
accord healthcare limited - marea britanie - rosuvastatinum - compr. film. - 10mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
astrium 20 mg
accord healthcare limited - marea britanie - rosuvastatinum - compr. film. - 20mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
astrium 40 mg
accord healthcare limited - marea britanie - rosuvastatinum - compr. film. - 40mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei
nevanac
novartis europharm limited - nepafenac - pain, postoperative; ophthalmologic surgical procedures - oftalmologice - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.